AssetMark Inc’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22
Closed -$85 3012
2025
Q1
$85 Hold
22
﹤0.01% 2576
2024
Q4
$85 Hold
22
﹤0.01% 2541
2024
Q3
$161 Sell
22
-61
-73% -$400 ﹤0.01% 2185
2024
Q2
$535 Hold
83
﹤0.01% 1919
2024
Q1
$874 Hold
83
﹤0.01% 1685
2023
Q4
$732 Sell
83
-21
-20% -$160 ﹤0.01% 1653
2023
Q3
$854 Hold
104
﹤0.01% 1539
2023
Q2
$1.21K Sell
104
-30
-22% -$284 ﹤0.01% 1458
2023
Q1
$1.03K Sell
134
-232
-63% -$1.88K ﹤0.01% 1445
2022
Q4
$3.37K Sell
366
-153
-29% -$1.7K ﹤0.01% 1393
2022
Q3
$5K Sell
519
-63,519
-99% -$794K ﹤0.01% 1291
2022
Q2
$914K Buy
64,038
+29,055
+83% +$497K ﹤0.01% 517
2022
Q1
$652K Buy
+34,983
New +$662K ﹤0.01% 575

Other funds holding BAK

AssetMark Inc's BAK Position: Q2 2025 in Review

AssetMark Inc sold out of Braskem (BAK) in Q2 2025, closing a stake of 22 shares — an estimated $85 sold.

AssetMark Inc first reported a position in BAK in Q1 2022 and held it in 13 quarters. The position peaked at $914K in Q2 2022. 52 funds tracked by Wall St. Rank hold BAK as of Q2 2025.

  • AssetMark Inc reported no remaining Braskem position as of Q2 2025 after selling out during the quarter.
  • AssetMark Inc sold 22 Braskem shares in Q2 2025, an estimated $85.
  • AssetMark Inc first reported a position in Braskem in Q1 2022 and held it in 13 quarters.
  • AssetMark Inc's Braskem position peaked at $914K in Q2 2022.
  • 52 funds tracked by Wall St. Rank held Braskem as of Q2 2025.

Based on AssetMark Inc's 13F filing for Q2 2025, filed 4 Aug 2025.